EUVIMEDEUVIMED entdecken
Crossref

Soluble levels of 4‐1BB (CD137) and OX40 (CD134) are associated with cancer progression in gastric adenocarcinoma

Cecilia Araújo Carneiro Lima, Mário Rino Martins, Rogerio Luiz Dos Santos, Luciana Mata da Silva, Jeronimo Paulo Assis Da Silva, Nora Manoukian Forones, Leuridan Cavalcante Torres

Journal of Surgical Oncology · 2024

DOI: 10.1002/jso.27726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Cecilia Araújo Carneiro Lima und 6 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Laboratory Prof CA Hart (IMIP), Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil. Hauptthemen laut MEDLINE: Stomach Neoplasms, Tumor Necrosis Factor Receptor Superfamily, Member 9, Adenocarcinoma, Disease Progression. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Fundação de Amparo à Ciência e Tecnologia de Pernambuco, Ministério da Saúde, Programa Nacional de Apoio à Atenção Oncológica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Previous studies have demonstrated that soluble forms of T‐cell costimulatory molecules 4‐1BB (s4‐1BB) and OX40 (sOX40) interact with immune cells and may constitute a mechanism of immune evasion by tumors in various cancers. The role of the soluble forms of 4‐1BB and OX40 in GC remains unclear. We aimed to examine the association between serum levels of s4‐1BB and sOX40 and tumor progression in patients with GC.

Methods

Between 2017 and 2018, a cross‐sectional study was performed with serum samples of 83 GC patients and 20 healthy controls.

Results

Patients with stage IV metastatic gastric cancer had significantly higher levels of soluble OX40 in comparison with stage III patients with lymph nodes metastasis ( p = 0.0003) and stages I and II patients ( p = 0.005), whereas the opposite was found for soluble 4‐1BB levels, with lower levels being found in advanced stage III ( p = 0.003) compared with initial stages I/II.

Conclusions

The sOX40 and s4‐1BB‐mediated T cell interactions may be involved in antitumor immune responses in GC, possibly favoring tumor escape and progression. Serum levels of sOX40 and s4‐1BB are associated with staging in GC and may constitute biomarkers for prognosis, as well as potential targets for immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsTumor Necrosis Factor Receptor Superfamily, Member 9AdenocarcinomaDisease ProgressionReceptors, OX40Biomarkers, TumorHumansMaleFemaleMiddle AgedAgedCross-Sectional StudiesCase-Control StudiesPrognosisAdultFollow-Up StudiesNeoplasm StagingLymphatic MetastasisAged, 80 and over

Stichwörter der Autor:innen

gastric cancerimmunotherapyreceptor 4‐1BBreceptor OX40tumor escapetumor necrosis factor receptor superfamily

Substanzen

Tumor Necrosis Factor Receptor Superfamily, Member 9Receptors, OX40Biomarkers, TumorTNFRSF4 protein, humanTNFRSF9 protein, human

Autor:innen und Institutionen

  • Translational Research Laboratory Prof CA Hart (IMIP), Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil.
  • Hospital de Câncer de Pernambuco, Recife, Brazil.
  • Postgraduate program in translational medicine, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
  • Real Instituto de Cirurgia Oncológica (RICO-RHP), Recife, Brazil.
  • Department of Digestive Surgery, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.

Förderung

  • Fundação de Amparo à Ciência e Tecnologia de Pernambuco
  • Ministério da Saúde, Programa Nacional de Apoio à Atenção Oncológica

Zitieren

APA

Lima, C. A. C., Martins, M. R., Dos Santos, R. L., da Silva, L. M., Da Silva, J. P. A., Forones, N. M., & Torres, L. C. (2024). Soluble levels of 4‐1BB (CD137) and OX40 (CD134) are associated with cancer progression in gastric adenocarcinoma. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27726

Vancouver

Lima CAC, Martins MR, Dos Santos RL, da Silva LM, Da Silva JPA, Forones NM, et al. Soluble levels of 4‐1BB (CD137) and OX40 (CD134) are associated with cancer progression in gastric adenocarcinoma. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27726

BibTeX
@article{Lima2024,
  author = {Lima, Cecilia Araújo Carneiro and Martins, Mário Rino and Dos Santos, Rogerio Luiz and da Silva, Luciana Mata and Da Silva, Jeronimo Paulo Assis and Forones, Nora Manoukian and Torres, Leuridan Cavalcante},
  title = {Soluble levels of 4‐1BB (CD137) and OX40 (CD134) are associated with cancer progression in gastric adenocarcinoma},
  journal = {Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1002/jso.27726}
}
Kostenlos starten →